Manganese Dioxide-Entrapping Dendrimers Co-Deliver Protein and Nucleotide for Magnetic Resonance Imaging-Guided Chemodynamic/Starvation/Immune Therapy of Tumors DOI
Yue Gao,

Zhijun Ouyang,

Siyan Shen

и другие.

ACS Nano, Год журнала: 2023, Номер 17(23), С. 23889 - 23902

Опубликована: Ноя. 25, 2023

Development of a nanoscale drug delivery system that can simultaneously exert efficient tumor therapeutic efficacy while creating the desired antitumor immune responses is still challenging. Herein, we report use manganese dioxide (MnO2)-entrapping dendrimer nanocarrier to codeliver glucose oxidase (GOx) and cyclic GMP-AMP (cGAMP), an agonist stimulator interferon genes (STING) for improved chemodynamic/starvation/immune therapy. Methoxy poly(ethylene glycol) (mPEG)- phenylboronic acid (PBA)-modified generation 5 (G5) poly(amidoamine) dendrimers were first synthesized then entrapped with MnO2 nanoparticles (NPs) generate hybrid MnO2@G5-mPEG–PBA (MGPP) NPs. The created MGPP NPs core size 2.8 nm display glutathione depletion ability, favorable Mn2+ release profile under microenvironment mimetic condition enable Fenton-like reaction T1-weighted magnetic resonance (MR) imaging. We show MGPP-mediated GOx facilitates enhanced chemodynamic/starvation therapy cancer cells in vitro, further codelivery cGAMP effectively trigger immunogenic cell death (ICD) strongly promote maturation dendritic cells. In bilateral mouse colorectal model, nanosystem elicits potent performance strong abscopal effect, greatly improving overall survival rate. Importantly, dendrimer-mediated not only allows coordination respective chemodynamic/starvation-triggered ICD augmented STING activation boost systemic responses, but also enables MR imaging, potentially serving as promising nanoplatform responses.

Язык: Английский

Manganese‐Based Tumor Immunotherapy DOI
Ke Zhang, Chao Qi, Kaiyong Cai

и другие.

Advanced Materials, Год журнала: 2022, Номер 35(19)

Опубликована: Сен. 19, 2022

Abstract As an essential micronutrient, manganese (Mn) participates in various physiological processes and plays important roles host immune system, hematopoiesis, endocrine function, oxidative stress regulation. Mn‐based nanoparticles are considered to be biocompatible show versatile applications nanomedicine, particular utilized tumor immunotherapy the following ways: 1) acting as a nanocarrier deliver immunotherapeutic agents for immunotherapy; 2) serving adjuvant regulate microenvironment enhance 3) activating host's system through cGAS‐STING pathway trigger 4) real‐time monitoring effect by magnetic resonance imaging (MRI) since Mn 2+ ions ideal MRI contrast agent which can significantly T 1 ‐weighted signal after binding proteins. This comprehensive review focuses on most recent progress of nanoplatforms immunotherapy. The characteristics first discussed guide design multifunctional nanoplatforms. Then biomedical nanoplatforms, including alone, immunotherapy‐involved multimodal synergistic therapy, imaging‐guided detail. Finally, challenges future developments highlighted.

Язык: Английский

Процитировано

177

Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy DOI Creative Commons

Yunrong Yang,

Jia Huang, Min Liu

и другие.

Advanced Science, Год журнала: 2022, Номер 10(2)

Опубликована: Ноя. 27, 2022

Cancer immunotherapy effect can be greatly enhanced by other methods to induce immunogenic cell death (ICD), which has profoundly affected as a highly efficient paradigm. However, these treatments have significant limitations, either causing damage of the immune system or limited superficial tumors. Sonodynamic therapy (SDT) ICD promote without affecting because its excellent spatiotemporal selectivity and low side effects. Nevertheless, SDT is still reactive oxygen species yield complex tumor microenvironment. Recently, some emerging SDT-based nanomedicines made numerous attractive encouraging achievements in field cancer due high immunotherapeutic efficiency. this cross-cutting research far from being widely explored huge professional barriers. Herein, characteristics microenvironment mechanisms are firstly systematically summarized. Subsequently, therapeutic mechanism fully summarized, advantages limitations discussed. The representative advances for further highlighted. Finally, application prospects challenges future clinical translation

Язык: Английский

Процитировано

143

Bioactive inorganic nanomaterials for cancer theranostics DOI
Zifan Pei,

Huali Lei,

Liang Cheng

и другие.

Chemical Society Reviews, Год журнала: 2023, Номер 52(6), С. 2031 - 2081

Опубликована: Янв. 1, 2023

Bioactive materials are a special class of biomaterials that can react in vivo to induce biological response or regulate functions, thus achieving better curative effect than traditional inert biomaterials. For cancer theranostics, compared with organic polymer nanomaterials, inorganic nanomaterials possess unique physical and chemical properties, have stronger mechanical stability on the basis maintaining certain bioactivity, easy be compounded various carriers (polymer carriers, etc.), so as achieve specific antitumor efficacy. After entering nanoscale, due nano-size effect, high surface area nanostructures, exhibit effects, which significantly influence interaction organisms. Therefore, research applications bioactive theranostics attracted wide attention. In this review, we mainly summarize recent progress also introduce definition, synthesis modification strategies nanomaterials. Thereafter, tumor imaging therapy, including microenvironment (TME) regulation, catalytic gas regulatory cell death immunotherapy, discussed. Finally, biosafety challenges mentioned, their future development opportunities prospected. This review highlights bioapplication

Язык: Английский

Процитировано

137

Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy DOI
Shuang Liang, Jianjun Yao, Dan Liu

и другие.

Advanced Materials, Год журнала: 2023, Номер 35(33)

Опубликована: Март 7, 2023

Abstract Immunotherapy has made remarkable strides in cancer therapy over the past decade. However, such emerging still suffers from low response rates and immune‐related adverse events. Various strategies have been developed to overcome these serious challenges. Therein, sonodynamic (SDT), as a non‐invasive treatment, received ever‐increasing attention especially treatment of deep‐seated tumors. Significantly, SDT can effectively induce immunogenic cell death trigger systemic anti‐tumor immune response, termed immunotherapy. The rapid development nanotechnology revolutionized effects with robust induction. As result, more innovative nanosonosensitizers synergistic modalities are established superior efficacy safe profile. In this review, recent advances immunotherapy summarized particular emphasis on how be explored harness for amplifying response. Moreover, current challenges field prospects its clinical translation also presented. It is anticipated that review provide rational guidance facilitate nanomaterials‐assisted immunotherapy, helping pave way next‐generation eventually achieve durable patients.

Язык: Английский

Процитировано

136

The promising interplay between sonodynamic therapy and nanomedicine DOI
Roberto Canaparo, Federica Foglietta, Nadia Barbero

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2022, Номер 189, С. 114495 - 114495

Опубликована: Авг. 17, 2022

Язык: Английский

Процитировано

100

Reactive oxygen species-powered cancer immunotherapy: Current status and challenges DOI

Mengying He,

Mengyuan Wang,

Tao Xu

и другие.

Journal of Controlled Release, Год журнала: 2023, Номер 356, С. 623 - 648

Опубликована: Март 21, 2023

Язык: Английский

Процитировано

95

Biomineralized MnO2 Nanoplatforms Mediated Delivery of Immune Checkpoint Inhibitors with STING Pathway Activation to Potentiate Cancer Radio-Immunotherapy DOI
Zheng Deng, Min Xi, Cai Zhang

и другие.

ACS Nano, Год журнала: 2023, Номер 17(5), С. 4495 - 4506

Опубликована: Фев. 27, 2023

Radiotherapy (RT), as one of the main methods in clinical treatment various malignant tumors, would induce systemic immunotherapeutic effects by triggering immunogenic cell death (ICD) cancer cells. However, antitumor immune responses produced RT-induced ICD alone usually are not robust enough to eliminate distant tumors and thus ineffective against metastases. Herein, a biomimetic mineralization method for facile synthesis MnO2 nanoparticles with high anti-programmed ligand 1 (αPDL1) encapsulation efficiency (αPDL1@MnO2) is proposed reinforce responses. This therapeutic nanoplatforms-mediated RT can significantly improve killing tumor cells effectively evoke overcoming hypoxia-induced radio-resistance reprogramming immunosuppressive microenvironment (TME). Furthermore, released Mn2+ ions from αPDL1@MnO2 under acidic pH activate cyclic GMP-AMP synthase (cGAS)-stimulator interferon genes (STING) pathway facilitate dendritic (DCs) maturation. Meanwhile, αPDL1 further promote intratumoral infiltration cytotoxic T lymphocytes (CTLs) trigger responses, resulting strong abscopal effect inhibit Overall, biomineralized MnO2-based nanoplatforms offer simple strategy TME modulation activation, which promising enhanced immunotherapy.

Язык: Английский

Процитировано

92

Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy DOI
Jiexin Li, He Ren, Qian Qiu

и другие.

ACS Nano, Год журнала: 2022, Номер 16(10), С. 16909 - 16923

Опубликована: Окт. 6, 2022

Cancer immunotherapy holds great promise but is generally limited by insufficient induction of anticancer immune responses. Here, a metal micellar nanovaccine developed the self-assembly manganese (Mn), stimulator interferon genes (STING) agonist (ABZI) and naphthalocyanine (ONc) coordinated nanoparticles (ONc-Mn-A) in maleimide-modified Pluronic F127 (malF127) micelles. Owing to synergy between Mn ABZI, nanovaccine, termed ONc-Mn-A-malF127, elevates levels interferon-β (IFNβ) 324- 8-fold vivo, compared use or ABZI alone. As such, activation cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)-STING pathway induces sufficient dendritic cell (DC) maturation, eventually resulting death CD8+ T cell-sensitive tumors cell-resistant simultaneously promoting cytotoxic cells NK cells, respectively. Furthermore, with ONc used as chelator an efficient photosensitizer, photoinduced immunogenic (ICD) tumor releases damage-associated molecular patterns (DAMPs) neoantigens from dying primary upon laser irradiation, which are captured situ malF127 then transported DCs. After treatment, addition photothermal therapy, responses characterized level IFNβ further elevated another 4-fold. In murine cancer models, ICD-based metalloimmunotherapy using ONc-Mn-A-malF127 single dose intravenous injection achieved eradication distant tumors. Taken together, offers nanoplatform enhance efficacy ICD based strong abscopal effect.

Язык: Английский

Процитировано

88

Organic Sonodynamic Materials for Combination Cancer Immunotherapy DOI
Chi Zhang, Kanyi Pu

Advanced Materials, Год журнала: 2023, Номер 35(51)

Опубликована: Июнь 1, 2023

Sonodynamic therapy (SDT) is a promising non-invasive therapeutic modality to treat deep-seated tumors owing the good tissue penetration ability and spatiotemporal controllability of ultrasound (US); however, low sonodynamic activity potential side effects greatly limit its clinical translation. Cancer immunotherapy that leverages immune system fight against cancer has great synergize with SDT for treatment high efficiency safety. In this review, convergence exert their merits break through limitations combination sono-immunotherapy are discussed. The focus on development construction organic materials immunotherapeutic efficiency. These not only induce immunogenic cell death improve tumor immunogenicity via but also activate antitumor immunity immuno-oncology drug-mediated pathway modulation. various drugs sonosensitizers categorized discussed along prospects challenges

Язык: Английский

Процитировано

83

Cancer cell membrane-coated C-TiO2 hollow nanoshells for combined sonodynamic and hypoxia-activated chemotherapy DOI
Shipeng Ning, Xingliang Dai,

Weiwei Tang

и другие.

Acta Biomaterialia, Год журнала: 2022, Номер 152, С. 562 - 574

Опубликована: Сен. 5, 2022

Язык: Английский

Процитировано

74